Skip to content
Shoreline Biosciences
  • Home
  • About Us
    • Leadership Team
    • Directors
    • Scientific Advisory Board
    • Investors & Partners
  • Our Science
    • Platform
    • iNK
    • iMACs
  • News
  • Join Us!
  • Contact
  • Home
  • About Us
    • Leadership Team
    • Directors
    • Scientific Advisory Board
    • Investors & Partners
  • Our Science
    • Platform
    • iNK
    • iMACs
  • News
  • Join Us!
  • Contact
Shoreline Biosciences
  • Home
  • About Us
    • Leadership Team
    • Directors
    • Scientific Advisory Board
    • Investors & Partners
  • Our Science
    • Platform
    • iNK
    • iMACs
  • News
  • Join Us!
  • Contact
  • Home
  • About Us
    • Leadership Team
    • Directors
    • Scientific Advisory Board
    • Investors & Partners
  • Our Science
    • Platform
    • iNK
    • iMACs
  • News
  • Join Us!
  • Contact

    Featured News

    Shoreline Biosciences Wins a Comprehensive Summary Judgement Victory on All Claims Brought by Fate Therapeutics and Whitehead Institute on iPSC Generation and Use

    September 7, 2023
    Read More

    A highly efficient transgene knock-in technology in clinically relevant cell types

    June 20, 2023
    Read More

    Press Releases

    Shoreline Biosciences Wins a Comprehensive Summary Judgement Victory on All Claims Brought by Fate Therapeutics and Whitehead Institute on iPSC Generation and Use

    September 7, 2023
    READ MORE

    Shoreline Biosciences to Participate at the 2023 Wedbush Pacgrow Healthcare Conference

    August 3, 2023
    READ MORE

    Shoreline Biosciences Announces Appointment of Steve Potter as Vice President of People and Culture

    June 16, 2023
    READ MORE

    Shoreline Biosciences to Present Data at AACR 2023 Demonstrating Novel Methodology to Produce Clinical Scale iPSC-derived NK (iNK) Cells

    March 16, 2023
    READ MORE

    Shoreline Biosciences to Present Data at AACR 2023 Demonstrating Novel Methodology to Produce Clinical Scale iPSC-derived NK (iNK) Cells

    March 16, 2023
    READ MORE

    Shoreline Biosciences Announces Appointment of Mauro P. Avanzi, M.D., Ph.D., As Chief Medical Officer

    February 21, 2023
    READ MORE
    LOAD MORE

    Media

    A highly efficient transgene knock-in technology in clinically relevant cell types

    June 20, 2023
    READ MORE

    A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs

    July 9, 2022
    READ MORE

    BioWorld Insider Podcast: One-on-one with Medical Innovators

    February 7, 2022
    READ MORE

    BioWorld Insider Podcast: One-on-one with Medical Innovators

    December 10, 2021
    READ MORE

    Harnessing the body’s natural killers to target cancer

    December 5, 2021
    READ MORE

    Intelligent Cells: Shoreline Builds Immunotherapy Platform, Pipeline with $140M Financing

    November 8, 2021
    READ MORE
    LOAD MORE
    Shoreline Biosciences
    • 10220 Sorrento Valley Road
      San Diego, CA 92121
    • Email Shoreline
    Linkedin

    Join Our Newsletter

    ©2023 Shoreline Biosciences. All Rights Reserved.